Literature DB >> 17035654

Alzheimer's disease--clinical trials and the logic of clinical purpose.

Jason Karlawish.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035654     DOI: 10.1056/NEJMe068163

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Quality of mental health care for nursing home residents: a literature review.

Authors:  David C Grabowski; Kelly A Aschbrenner; Vincent F Rome; Stephen J Bartels
Journal:  Med Care Res Rev       Date:  2010-03-11       Impact factor: 3.929

Review 2.  Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?

Authors:  Robert E Becker; Nigel H Greig; Ezio Giacobini
Journal:  J Alzheimers Dis       Date:  2008-10       Impact factor: 4.472

3.  Documentation of antipsychotic use and indications for newly diagnosed, nonaggressive dementia patients.

Authors:  Nikhil Dhawan; Avila B Steele; Robert O Morgan; A Lynn Snow; Jessica A Davila; Mark E Kunik
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

4.  Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors:  Robert E Becker; Nigel H Greig
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

5.  Mexiletine therapy for chronic pain: survival analysis identifies factors predicting clinical success.

Authors:  Ian R Carroll; Kimberly M Kaplan; Sean C Mackey
Journal:  J Pain Symptom Manage       Date:  2008-01-28       Impact factor: 3.612

Review 6.  Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials.

Authors:  Roberto Raschetti; Emiliano Albanese; Nicola Vanacore; Marina Maggini
Journal:  PLoS Med       Date:  2007-11-27       Impact factor: 11.069

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.